Combination Therapy and Single-Modality Treatment for Acute Low-Tone Hearing Loss: A Meta-Analysis with Trial Sequential Analysis
Open Access
- 30 June 2022
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 12 (7) , 866
Abstract
Acute low-tone hearing loss (ALHL) is a common clinical disease and was first proposed by Abe in 1981 as sensorineural hearing loss confined to low frequencies. The best strategy for initiating medication is still unclear, as the superiority of steroids and diuretics is still debated, and combination therapy might yield additional benefits. However, no study regarding combination therapy has been published. The objective of this study was to evaluate the efficacy of steroid therapy versus combination therapy of diuretics with steroids by conducting a systematic review with a meta-analysis and trial sequential analysis (TSA). Studies enrolling patients with a diagnosis of acute low-tone hearing loss were considered eligible. After searching the PubMed, Cochrane Library, Embase, Scopus and Web of Science databases from inception to 31 December 2021, five studies including 433 patients were enrolled. Overall, the comparison between combination therapy with steroids and diuretics and single-modality treatment with steroids (OR, 1.15; 95% CI, 0.51 to 2.59; p = 0.74; I2 = 34%) and the comparison between combination therapy and treatment with diuretics alone (OR, 1.73; 95% CI, 0.93 to 3.23; p = 0.09; I2 = 5%) showed that combination therapy did not confer significant benefits when compared to single-modality treatments. A trial sequential analysis (TSA) showed conclusive nonsignificant results of the comparison between the combination of steroids and diuretics and a single-modality treatment. In conclusion, we reported that the combination of steroids and diuretics did not yield significant benefits when compared to single-modality treatment with steroids or diuretics. We suggest that treatment should be initiated with steroids or diuretics alone to avoid potential adverse effects.Keywords
Funding Information
- Taipei Veterans General Hospital (V109D49-004-MY2-1, V110C-123)
This publication has 30 references indexed in Scilit:
- Trial of Chinese Medicine Wu-Ling-San for Acute Low-Tone Hearing LossORL, 2012
- A Comparison of the Short-Term Outcome in Patients with Acute Low-Tone Sensorineural Hearing LossORL, 2010
- Effect of Corticosteroids or Diuretics in Low-Tone Sensorineural Hearing LossORL, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Immunological Responses in Acute Low-tone Sensorineural Hearing Loss and Ménière's DiseaseActa Oto-Laryngologica, 2003
- Can Migraine Damage the Inner Ear?Archives of Neurology, 2000
- Strial Dysfunction in the MRL‐Faslpr mouseOtolaryngology–Head and Neck Surgery, 1999
- Clinical Observations on Acute Low-Tone Sensorineural Hearing LossAnnals of Otology, Rhinology & Laryngology, 1997
- Assessment of Serum Antibodies in Patients With Rapidly Progressive SensorineuralHearing Loss and Meniere's DiseaseThe Laryngoscope, 1995
- Acute Low-Tone Sensorineural Hearing Loss Without VertigoJAMA Otolaryngology–Head & Neck Surgery, 1994